Kovack Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
BCM
TWM
FGA
CWG
EFG
PFA
APA
Kovack Advisors's BTAL Position: Q1 2023 in Review
Kovack Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2023, closing a stake of 24,408 shares — an estimated $518K sold.
Kovack Advisors first reported a position in BTAL in Q4 2022 and held it in 1 quarter. The position peaked at $518K in Q4 2022. 89 funds tracked by Wall St. Rank hold BTAL as of Q1 2023.
- Kovack Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2023 after selling out during the quarter.
- Kovack Advisors sold 24,408 AGF US Market Neutral Anti-Beta Fund shares in Q1 2023, an estimated $518K.
- Kovack Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and held it in 1 quarter.
- Kovack Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $518K in Q4 2022.
- 89 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2023.
Based on Kovack Advisors's 13F filing for Q1 2023, filed 21 Apr 2023.